114611-53-9 114611-53-9 seller in China 114611-53-9 factory in China
Lorcaserin(856681-05-5)is an orally administered agent and a selective 5-HT2C receptor agonist for the treatment of obesity. It had been approved for marketing in US by FDA on 27 June in 2012. In clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
17-Iodoandrosta-5,16-dien-3beta-acetate ester 98% CAS No.114611-53-9
Product Name: 17-Iodoandrosta-5,16-dien-3beta-acetate ester
Synonyms: Abiraterone Intermediate;
17-Iodoandrosta-5,16-dien-3beta-ol 3-acetate
Abiraterone Acetate InterMediate;
(3S,8R,9S,10R,13S,14S)-17-Iodo-10,13-dimethyl-2,3,4,7,8,9,10,11, 12,13,14,15-dodecahydro-1H-cyclo;
17-Iodoandrosta-5,16-dien-3β-acetate ester;
(3beta)-17-iodo-Androsta-5,16-dien-3-ol 3-acetate;
(3S,8R,9S,10R,13S,14S)-17-Iodo-10,13-diMethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
CAS No.: 114611-53-9
Molecular Formula: C21H27IO
Molecular Weight: 440.36
Molecular Structure:
Specification & COA: Please contact us
Packing:
CAS NO:7647-15-6
CAS NO:420-37-1
CAS NO:13598-36-2
CAS NO:97416-84-7
CAS NO:15761-39-4
CAS NO:118-75-2
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View